Enrica Rumiato Selected Research

Cisplatin (Platino)

11/2013

ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enrica Rumiato Research Topics

Disease

5	Esophageal Neoplasms (Esophageal Cancer) 01/2020 - 11/2011
5	Neoplasms (Cancer) 01/2019 - 11/2011
2	Carcinogenesis 12/2017 - 11/2011
2	Adenocarcinoma 10/2016 - 11/2011
1	Barrett Esophagus (Barrett's Esophagus) 12/2017
1	Glioblastoma (Glioblastoma Multiforme) 10/2015
1	Breast Neoplasms (Breast Cancer) 01/2015
1	Hodgkin Disease (Hodgkin's Disease) 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 08/2013
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 03/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2011
1	Genomic Instability 11/2011

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 10/2016 - 11/2011
2	PlatinumIBA 01/2020 - 05/2016
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2011
2	Cell-Free Nucleic AcidsIBA 12/2017 - 10/2016
1	Temozolomide (Temodar)FDA LinkGeneric 10/2015
1	Cisplatin (Platino)FDA LinkGeneric 11/2013
1	Fluorouracil (Carac)FDA LinkGeneric 11/2013
1	Glutathione Transferase (Glutathione S-Transferase)IBA 11/2013
1	Thymidylate SynthaseIBA 11/2013
1	EnzymesIBA 08/2013

Therapy/Procedure

3	Therapeutics 01/2020 - 08/2013
3	Drug Therapy (Chemotherapy) 05/2016 - 03/2012
3	Neoadjuvant Therapy 05/2016 - 11/2013
2	Radiotherapy 10/2015 - 01/2015
1	Chemoradiotherapy 01/2016
1	Ligation 11/2011